Senior insider sale
EVP, Chief Technical Ops. Off. at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$1.09M
2.50K shares
What this filing means
ATKINSON EDWARD MORROW III plans to sell 2.50K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $1.09M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/17/2025ACC: 0001959173-25-007041
Officer· EVP, Chief Technical Ops. Off.
Since Feb 2026
2.50K
Shares to sell
$1.09M
Approx. market value
2.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Vesting
Compensation
2/17/2025
1.63KRestricted Stock Vesting
Compensation
2/24/2024
868.00Total acquired2.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/17/2025 | Restricted Stock Vesting Compensation | 1.63K | — |
2/24/2024 | Restricted Stock Vesting Compensation | 868.00 | — |
| Total | 2.50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.50K
Market value
$1.09M
11/17/2025
Total
Units
2.50K
Value
$1.09M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/17/2025 | 2.50K | $1.09M | NASDAQ | Planned |
| Total | 2.50K | $1.09M | ||